Kamal retweeted
🎉 A resounding success for the IAP Companion Meeting by GUPS!
@GU_Path_Society extends gratitude to the GUPS leadership, speakers Dr. Loda, @drmehrarohit @h_alahmadie Dr. Gupta & moderators @aimhaider @ckcding for their outstanding contributions
Kamal retweeted
Dr Al-Ahmadie teaching the therapeutic landscape of advanced and metastatic UCA @h_alahmadie @GU_Path_Society #gupath @rovingatuscap @DrCristinaMagi @aimhaider @ckcding @IAPCentral @IAPJapan
Kamal retweeted
The power of the p - Pathology is the gold standard for determining extent of cancer @IAPJapan @TheUSCAP @GU_Path_Society @UMichPath #cancer
Kamal retweeted
GUPS Session being moderated by Dr Haider and Dr Ding @GU_Path_Society @IAPCentral @IAPJapan #gupath @h_alahmadie @fadbrimo @aimhaider @ckcding @DrCristinaMagi @JaneNguyen44 @lalpritu @LotanLab
Kamal retweeted
GUPS specialty conference happening right now in Room 9 Sunpalace @GU_Path_Society @IACytology @IntSocUropath @IAPCentral @IAPJapan #gupath #genomics @h_alahmadie
Kamal retweeted
Great presentation by Dr Washington highlighting salient aspect of 9th version of AJCC- online only version with electronic product; to be released on ‘chapter by chapter ‘ basis @IAPJapan #iap2016 #uscap #cancer @UMichPath @Pathologists
Kamal retweeted
📣 Join GUPS at #IAP2026!
🧬 Molecular Interrogation of Genitourinary Malignancies with Clinicopathologic Annotations
🗓 Oct 11 | 18:00–20:00
📍 Sunplace, Room 9, 2F Palace Room
Featuring Dr. Massimo Loda, @drmehrarohit @h_alahmadie & Dr. Sounak Gupta
#GUPS #GUPath
Kamal retweeted
Join us on Thursday, Oct. 1 for our next Virtual Education Series: Bridges in Genitourinary Oncology- From Pathology Phenotypes to Clinical Realities.
Speakers: @TingZhaoPathdoc, @DrSwatiBhardwaj, Dr. Gabriela Quiroga-Garza.
🕛 12–1:30 PM EST
Register: us02web.zoom.us/webinar/regi…
Kamal retweeted
‘ Cancer is teaching me how to live’ - Amazing discussions at the #bladdercancer patient advocate session @BladderCancerUS #bcantt #CancerResearch
Kamal retweeted
The wait is finally over.
The New Brezza has arrived with two ways to play.
Turbo Boosterjet for the rush-seekers, and Refined K15C for the smooth-movers.
Book your test drive today at your nearest Maruti Suzuki Arena showroom and
Lead Every Play.
Kamal retweeted
.#Pathology education has historically depended on geography, institutional privilege, cost, and access. We wanted to challenge that. What started during the chaos of COVID became something much bigger.
Our new paper on @PathElective shows that a free, virtual, globally accessible pathology education platform reached learners across nearly every region of the world, across diverse backgrounds, training levels, identities, and lived experiences. More importantly, the data tell a deeper story.
Nearly a quarter of respondents reported difficulty accessing reliable internet. Less than half grew up in English-speaking households. Many were balancing jobs while training. And yet, 76% felt PathElective was more accessible than traditional educational resources, while 72% felt it filled an unmet educational need. That matters because education should not belong only to those born into the “right” systems.
For years, pathology has talked about visibility, access, pipeline development, and global engagement. This project was an attempt to actually build something instead of just talking about it.
Proud of this work and proud of the incredible collaborators who helped create PathElective. Proud that a pathology platform built with generosity and community at its core could reach people from around the world.
And honestly, I think this is just the beginning of what democratized medical education can become.
@AcadPathol @apcprods @UMichPath
#Pathology #MedEd #MedicalEducation #DigitalPathology #PathTwitter #FOAMed #GlobalHealth #Hematopathology #PathElective #AcademicMedicine #MedicalStudents #Residency #MedicalEducationResearch
clinicalkey.com/#!/content/p…
Kamal retweeted
📣 Join us for the next @GU_Path_Society Virtual Education Series!
🧬 Tumor Staging in GU Pathology (Part 1)
📅 June 23, 2026 | ⏰ 12–1:30 PM EST
Featuring: 👨⚕️ Dr. Tekin @buraktekinmd
👨⚕️ Dr. Sangoi @slusagar
👩⚕️ Dr. Siegmund
Register now 👉 us02web.zoom.us/webinar/regi…
Kamal retweeted
Dr. Argani @PeterArgani sharing how to distinguish degenerative changes from neoplastic and other pitfalls. Join us now in Ballroom B1 #GUPS2026 #USCAP2026 @TheUSCAP
Kamal retweeted
GUPS Poster Walk #2 at #USCAP2026 🔬
📍 Starting at poster #122 at 3:00 PM
👩⚕️ Led by Dr. Tamara Lotan @LotanLab
#GUPS #USCAP2026
Kamal retweeted
GUPS President @DrCristinaMagi with the Executive Committee at the end of an excellent and productive meeting. Thank you to the team @drmehrarohit @JaneNguyen44 @lalpritu @Tretiakova_Mar, speakers & moderators for their dedication, collaboration, and continued work!
#USCAP2026
Kamal retweeted
Dr. @DrCristinaMagi starting the AGM at #USCAP2026
Kamal retweeted
Poster walk by @GU_Path_Society in full swing @TheUSCAP #uscap #gupath #genomics #pathology @LotanLab
Kamal retweeted
Check out our new study @AJCPjournal highlighting utility of clinical ERG FISH testing in advanced & transdifferentiated #prostatecancer doi.org/10.1093/ajcp/aqaf128 @GU_Path_Society @IntSocUropath @RobHumbleMD @PCFnews @UMRogelCancer @MLabsUM @UMichPath
Kamal retweeted
A new study by @UMRogelCancer and #UMichPath finds that additional testing of FISH-negative renal cell carcinoma cases can reveal hidden MiTF gene rearrangements. TRIM63 overexpression may improve the accuracy of kidney cancer diagnosis. michmed.org/KDXN3





























